601
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

HLA Distribution in COPD Patients

, , , , , , , , & , 
PAC-COPD investigators listed in the Appendix , on behalf of the show all
Pages 138-146 | Published online: 20 Mar 2013

References

  • Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152:1666–1672.
  • Saetta M, Di Stefano A, Maestrelli P, Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147(2):301–306.
  • Rutgers SR, Postma DS, ten Hacken NH, Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55(1):12–18.
  • Willemse BWM, ten Hacken NHT, Rutgers B, Lesman-Leegte IGAT, Postma DS, Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005; 26(5):835–845.
  • Hogg JC, Chu F, Utokaparch S, The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2645–2653.
  • Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: Does COPD have an autoimmune component? Thorax 2003; 58(10):832–834.
  • Sullivan AK, Simonian PL, Falta MT, Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005; 172(5):590–596.
  • Cosio M, Saetta M, Agusti A. Immunological aspects of COPD. N Engl J Med 2009; 360:2445–2454.
  • Lee SH, Goswami S, Grudo A, Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13(5):567–569.
  • Taraseviciene-Stewart L, Scerbavicius R, Choe KH, An Animal Model of Autoimmune Emphysema. Am J Respir Crit Care Med 2005; 171(7):734–742.
  • Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. The nature of molecular recognition by T cells. Nat Immunol 2003; 4(3):217–224.
  • van der Merwe PA, Davis SJ. Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 2003; 21:659–684.
  • Flavell RA, Hafler DA. Autoimmunity. What is the turning point? Curr Opin Immunol 1999; 11(6):635–637.
  • Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000; 343(11):782–786.
  • Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol 2005; 14(3–4):175–182.
  • Heard R. HLA and autoimmune diseases. In: Lechler R, editor. HLA and Disease. London, UK: Academic Press Limited; 1994:123–151.
  • Kauffmann F, Kleisbauer JP, Cambon-De-Mouzon A, Genetic markers in chronic air-flow limitation. A genetic epidemiologic study. Am Rev Respir Dis. 1983; 127(3):263–269.
  • Maranetra N, Chandanayingyong D, Bovornkitti S. HLA antigen and ventilatory drive in Thais with chronic obstructive pulmonary disease. Asian Pac J Allergy Immunol 1990; 8(2):137–140.
  • Kasuga I, Ruan J, Connett JE, Anthonisen NR, Sandford AJ. Lack of association of human leukocyte antigen-B7 with COPD and rate of decline in lung function. Respir Med 2005; 99(12):1528–1533.
  • Garcia-Aymerich J, Gomez FP, Benet M, Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66:430–437.
  • Garcia-Aymerich J, Gomez FP, Anto JM. Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD study: Design and methods. Arch Bronconeumol 2009; 45(1):4–11.
  • Vidal S, Morante MP, Moga E, Molecular analysis of HLA-DRB1 polymorphism in north-east Spain. Eur J Immunogenet 2002; 29(1):75–77.
  • Simeon CP, Fonollosa V, Tolosa C, Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol 2009; 36(12):2733–2736.
  • Celli BR, MacNee W, Agusti AG, Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6):932–946.
  • Clausen JL. Pulmonary function testing. Guidelines and controversies. Equipment, Methods and Normal Values. 1 ed. Orlando: Grune & Stratton, Inc.; 1984.
  • Roca J, Rodriguez-Roisín R, Cobo E, Burgos F, Perez J, Clausen JL. Single-breath carbon monoxide diffusing capacity (DLCO) prediction equations for a mediterranean population. Am Rev Respir Dis 1990; 141:1026–1032.
  • Roca J, Sanchis J, Agustí-Vidal A, Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 1986; 22:217–224.
  • Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 2005; 1:47–50.
  • Miretti MM, Walsh EC, Ke X, A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005; 76(4):634–646.
  • Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology 2006; 11(6):731–740.
  • Kasuga I, Hogg JC, Pare PD, Role of genetic susceptibility to latent adenoviral infection and decreased lung function. Respir Med 2009; 103(11):1672–1680.
  • Pillai SG, Ge D, Zhu G, A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5(3):e1000421.
  • Rabe KF, Hurd S, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176(6):532–555.
  • Agusti A, Calverley P, Celli B, Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11(1):122–136.
  • Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 2003; 29(2):225–231.
  • Yamamoto-Furusho JK, Rodriguez-Bores L, Granados J. HLA-DRB1 Alleles are associated with the clinical course of disease and steroid dependence in mexican patients with ulcerative colitis. Colorectal Dis 2010; 12(12):1231–1235.
  • Tunca M, Musabak U, Sagkan RI, Koc E, Akar A. Association of human leukocyte antigen class II alleles with pemphigus vulgaris in a Turkish population. J Dermatol 2010; 37(3):246–250.
  • Kotb M, Norrby-Teglund A, McGeer A, An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8(12):1398–1404.
  • Taylor AE, Finney-Hayward TK, Quint JK, Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010; 35(5):1039–1047.
  • Sethi S, Mallia P, Johnston SL. New Paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc Amer Thorac Soc 2009; 6(6):532–534.
  • Greene CS, Penrod NM, Williams SM, Moore JH. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One 2009; 4:e5639.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.